Colitis ulcerative
RecruitingStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
- Disease:Colitis ulcerative
- Substances:–
Lithuania- Participants:18–64 years · 65+ years
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Back to Lithuania61 clinical trials in Klaipeda, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
Lithuania
LithuaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on systemic sclerosis, psoriatic arthritis, and ulcerative colitis. Studies are evaluating novel therapies including efgartigimod and sonelokimab to improve patient outcomes.
These trials aim to develop more effective treatments for chronic inflammatory conditions affecting multiple body systems.
Groundbreaking studies in multiple sclerosis treatment, particularly focusing on relapsing-remitting forms. Research includes comparative studies of new biologics and established treatments.
Clinical trials are exploring innovative approaches to improve neurological function and quality of life.
Studies targeting heart failure and atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiac events and improving heart function.
Research focuses on both preventive measures and treatment of established cardiovascular conditions.
Advanced research in prostate cancer and bladder cancer, evaluating new treatment approaches including targeted therapies and hormone treatments.
Trials aim to improve survival rates and quality of life for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.